X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4096) 4096
Publication (375) 375
Newsletter (43) 43
Magazine Article (26) 26
Book Chapter (9) 9
Book Review (7) 7
Conference Proceeding (4) 4
Book / eBook (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
neomycin - pharmacology (2874) 2874
animals (1940) 1940
humans (1137) 1137
neomycin (906) 906
anti-bacterial agents - pharmacology (889) 889
male (674) 674
rats (652) 652
streptomycin - pharmacology (556) 556
mice (464) 464
female (462) 462
index medicus (417) 417
biochemistry & molecular biology (398) 398
chloramphenicol - pharmacology (375) 375
tetracycline - pharmacology (354) 354
kanamycin - pharmacology (353) 353
drug resistance, microbial (340) 340
pharmacology & pharmacy (309) 309
escherichia coli - drug effects (304) 304
in vitro techniques (279) 279
antibiotics (274) 274
microbial sensitivity tests (264) 264
penicillin resistance (252) 252
gentamicins - pharmacology (248) 248
calcium - metabolism (245) 245
cells, cultured (226) 226
kinetics (225) 225
time factors (225) 225
research article (215) 215
erythromycin - pharmacology (208) 208
cell biology (205) 205
cell line (202) 202
dose-response relationship, drug (200) 200
research (199) 199
neomycin - therapeutic use (191) 191
penicillins - pharmacology (183) 183
bacteria - drug effects (181) 181
transfection (179) 179
mutation (177) 177
staphylococcus - drug effects (174) 174
microbiology (164) 164
neomycin - administration & dosage (164) 164
ampicillin - pharmacology (160) 160
bacitracin - pharmacology (155) 155
molecular sequence data (153) 153
rabbits (151) 151
neurosciences (147) 147
polymyxins - pharmacology (147) 147
adult (146) 146
pharmacology (142) 142
base sequence (139) 139
aminoglycosides (135) 135
expression (135) 135
guinea pigs (127) 127
intestines - microbiology (126) 126
aminoglycoside antibiotics (125) 125
cells (125) 125
calcium - pharmacology (121) 121
aminoglycosides - pharmacology (120) 120
drug resistance (120) 120
oxytetracycline - pharmacology (119) 119
hydrogen-ion concentration (118) 118
bacteria (117) 117
calcium (115) 115
plasmids (115) 115
anti-bacterial agents (113) 113
cattle (113) 113
culture media (111) 111
middle aged (111) 111
drug resistance - genetics (107) 107
neomycin - toxicity (107) 107
enzyme inhibitors - pharmacology (106) 106
genes (106) 106
feces - microbiology (104) 104
signal transduction (104) 104
genetic vectors (103) 103
drug resistance, microbial - genetics (102) 102
streptomycin (102) 102
phosphatidylinositols - metabolism (101) 101
protein synthesis inhibitors - pharmacology (101) 101
rats, inbred strains (101) 101
kanamycin (99) 99
physiology (99) 99
antibacterial agents (98) 98
binding (98) 98
neomycin - metabolism (98) 98
biotechnology & applied microbiology (96) 96
analysis (95) 95
chlortetracycline - pharmacology (95) 95
dna (95) 95
drug synergism (95) 95
dogs (94) 94
rats, wistar (94) 94
erythromycin ethylsuccinate - pharmacology (93) 93
type c phospholipases - metabolism (92) 92
anti-bacterial agents - therapeutic use (91) 91
biophysics (90) 90
escherichia coli - metabolism (89) 89
anti-bacterial agents - chemistry (86) 86
drug combinations (84) 84
inhibition (84) 84
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3571) 3571
Russian (229) 229
German (154) 154
French (59) 59
Italian (50) 50
Polish (23) 23
Japanese (18) 18
Czech (14) 14
Spanish (13) 13
Chinese (10) 10
Danish (7) 7
Ukrainian (7) 7
Dutch (5) 5
Romanian (3) 3
Portuguese (2) 2
Slovak (2) 2
Swedish (2) 2
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 4, pp. 328 - 341
Summary Background Many meta-analyses have shown reductions in infection rates and mortality associated with the use of selective digestive decontamination... 
Infectious Disease | MULTIPLE-TRAUMA PATIENTS | CONTROLLED CLINICAL-TRIAL | RANDOMIZED CONTROLLED-TRIALS | INFECTIOUS DISEASES | VENTILATOR-ASSOCIATED PNEUMONIA | DOUBLE-BLIND | OROPHARYNGEAL DECONTAMINATION | PLACEBO-CONTROLLED TRIAL | NOSOCOMIAL INFECTION | DIGESTIVE-TRACT DECONTAMINATION | CRITICALLY-ILL PATIENTS | United States - epidemiology | Prevalence | Gram-Positive Bacteria - drug effects | Humans | Tobramycin - pharmacology | Drug Resistance, Bacterial | Intensive Care Units - statistics & numerical data | Disease Transmission, Infectious - prevention & control | Cross Infection - transmission | Polymyxins - pharmacology | Digestive System - drug effects | Decontamination | Gentamicins - pharmacology | Vancomycin - pharmacology | Neomycin - pharmacology | Nystatin - pharmacology | Odds Ratio | Cephalosporins - pharmacology | Cross Infection - epidemiology | Oropharynx - microbiology | Anti-Infective Agents, Local - pharmacology | Cross Infection - prevention & control | Methicillin-Resistant Staphylococcus aureus - drug effects | South Africa - epidemiology | Amphotericin B - pharmacology | Europe - epidemiology | Clinical Trials as Topic | Pseudomonas aeruginosa - drug effects | Cross Infection - drug therapy | Randomized Controlled Trials as Topic | Gram-Negative Bacteria - drug effects | Anti-Infective Agents, Local - administration & dosage | Cross Infection - microbiology | Fluoroquinolones - pharmacology | Enterobacteriaceae - drug effects | Primary Prevention - methods | Anti-Bacterial Agents - pharmacology | Aminoglycosides - pharmacology | Anti-Bacterial Agents - administration & dosage | Digestive System - microbiology | Oropharynx - drug effects | Drug resistance in microorganisms | Analysis
Journal Article
Glia, ISSN 0894-1491, 04/2010, Volume 58, Issue 5, pp. 622 - 631
Production of nerve growth factor (NGF) from Schwann cells (SCs) progressively declines in the distal stump, if axonal regeneration is staggered across the... 
electrical stimulation | calcium | nerve growth factor | Schwann cell | nerve injuries | Electrical stimulation | Nerve growth factor | Calcium | Nerve injuries engineering | NEUROTROPHIC FACTOR | POOR FUNCTIONAL RECOVERY | AXONAL REGENERATION | GLIAL-CELLS | HIPPOCAMPAL-NEURONS | NEUROSCIENCES | PERIPHERAL-NERVE | RAT FEMORAL MOTONEURONS | DELAYED NERVE REPAIR | EXPRESSION | CONTRIBUTING FACTORS | Enzyme-Linked Immunosorbent Assay - methods | Calcium - metabolism | Tubulin Modulators - pharmacology | Nocodazole - pharmacology | Exocytosis - drug effects | Botulinum Toxins, Type A - pharmacology | Dose-Response Relationship, Drug | Estrenes - pharmacology | Pyrrolidinones - pharmacology | Egtazic Acid - analogs & derivatives | Neomycin - pharmacology | Caffeine - pharmacology | Cytochalasins - pharmacology | Protein Synthesis Inhibitors - pharmacology | Cadmium Chloride - pharmacology | Electric Stimulation - methods | Schwann Cells - drug effects | Animals, Newborn | Mibefradil - pharmacology | Nerve Growth Factor - metabolism | Cells, Cultured | Phosphodiesterase Inhibitors - pharmacology | Rats | S100 Proteins - metabolism | Schwann Cells - metabolism | Biophysics | Chelating Agents - pharmacology | Calcium Channel Blockers - pharmacology | Rats, Sprague-Dawley | Animals | Egtazic Acid - pharmacology | Analysis of Variance
Journal Article
Biochemical Journal, ISSN 0264-6021, 12/2011, Volume 440, Issue 3, pp. 355 - 365
Binding of specific microbial epitopes [MAMPs (microbe-associated molecular patterns)] to PRRs (pattern recognition receptors) and subsequent receptor kinase... 
Ionotropic glutamate receptor channel | Elicitor | Microbe-associated molecular pattern | Calcium channel | Calcium signature | Plant immunity | calcium channel | calcium signature | DEFENSE | GATED ION-CHANNEL | microbe-associated molecular pattern | SIGNATURES | elicitor | BIOCHEMISTRY & MOLECULAR BIOLOGY | CA2+ CHANNELS | PLANT-CELLS | ionotropic glutamate receptor channel | PLASMA-MEMBRANE | ROOT HAIRS | PERCEPTION | GENES | PATTERN-RECOGNITION RECEPTORS | plant immunity | Calcium Channels - metabolism | Seedlings - genetics | Type C Phospholipases - metabolism | Type C Phospholipases - antagonists & inhibitors | Arabidopsis Proteins - metabolism | Diltiazem - pharmacology | Estrenes - pharmacology | Plants, Genetically Modified | Pyrrolidinones - pharmacology | Gene Expression Regulation, Plant | Neomycin - pharmacology | Transcription, Genetic | Kynurenic Acid - pharmacology | Dideoxyadenosine - pharmacology | Arabidopsis Proteins - genetics | Nifedipine - pharmacology | Arabidopsis - drug effects | Receptors, Ionotropic Glutamate - metabolism | Aequorin - chemistry | Seedlings - drug effects | Calcium Channel Blockers - pharmacology | Chitin - pharmacology | Verapamil - pharmacology | Arabidopsis - metabolism | Arabidopsis - genetics | Receptors, Pattern Recognition | Bacterial Proteins - pharmacology | Calcium Signaling - drug effects | Alloxan - pharmacology | Mitogen-Activated Protein Kinases - genetics | Enzyme Activation | Arabidopsis Proteins - antagonists & inhibitors | Mitogen-Activated Protein Kinases - metabolism | Seedlings - metabolism
Journal Article
Apoptosis, ISSN 1360-8185, 4/2013, Volume 18, Issue 4, pp. 393 - 408
Journal Article
Journal Article
Digestive Diseases and Sciences, ISSN 0163-2116, 5/2015, Volume 60, Issue 5, pp. 1223 - 1231
Lipopolysaccharide decreases intestinal contractility and induces the production of cytokines, which play an important role in the pathogenesis of sepsis.The... 
Biochemistry, general | Medicine & Public Health | Cytokines | Interleukins | Hepatology | Gastroenterology | Lipopolysaccharide | Oncology | Intestinal contractility | Transplant Surgery | ACTIVATED PROTEIN-KINASE | CONTRACTILITY | RABBIT SMALL-INTESTINE | TUMOR-NECROSIS-FACTOR | ACETYLCHOLINE-RECEPTORS | INFLAMMATION | SMOOTH-MUSCLE-CELLS | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | INNATE IMMUNITY | Polymyxin B - pharmacology | Endotoxins | Gastrointestinal Motility - drug effects | Male | Substance P - pharmacology | Cell-Penetrating Peptides - pharmacology | Proteasome Endopeptidase Complex - drug effects | I-kappa B Kinase - metabolism | I-kappa B Kinase - antagonists & inhibitors | Potassium Chloride - pharmacology | Inflammation Mediators - metabolism | Neomycin - pharmacology | Duodenum - physiopathology | Toll-Like Receptor 4 - antagonists & inhibitors | Cytokines - genetics | Disease Models, Animal | Dinoprostone - pharmacology | Rabbits | Cytokines - metabolism | Proteasome Inhibitors - pharmacology | Signal Transduction | Acetylcholine - pharmacology | Gene Expression Regulation | Toll-Like Receptor 4 - genetics | Duodenum - enzymology | I-kappa B Kinase - genetics | Sepsis - physiopathology | Toll-Like Receptor 4 - metabolism | Sepsis - genetics | Proteasome Endopeptidase Complex - genetics | Leupeptins - pharmacology | Animals | Muscle Contraction | Sepsis - chemically induced | Sepsis - enzymology | Protein Kinase Inhibitors - pharmacology | Proteasome Endopeptidase Complex - metabolism | Duodenum - drug effects
Journal Article
Journal Article
Journal Article